Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
.png)
DeciBio Q&A
Clinical Diagnostics
Advances in Spatial Biology: A Q&A with Aneesh Acharya, CCO at Molecular Instruments
An interview with Aneesh Acharya, CCO of Molecular Instruments, discussing their bioimaging technology using Hybridization Chain Reaction (HCR), its role in spatial biology, and the company's shift towards clinical-grade solutions.
October 10, 2024
.png)
DeciBio Q&A
Clinical Diagnostics
Advances in Spatial Biology: A Q&A with Aneesh Acharya, CCO at Molecular Instruments
An interview with Aneesh Acharya, CCO of Molecular Instruments, discussing their bioimaging technology using Hybridization Chain Reaction (HCR), its role in spatial biology, and the company's shift towards clinical-grade solutions.
October 10, 2024
Spatial Biology
.png)
Newsletter Update
Clinical Diagnostics
AI / Machine Learning | September Round-Up
Welcome to our very first newsletter that covers the advances made by AI / ML across drug R&D, diagnostics, and the wider healthcare system.
October 9, 2024
.png)
Newsletter Update
Clinical Diagnostics
AI / Machine Learning | September Round-Up
Welcome to our very first newsletter that covers the advances made by AI / ML across drug R&D, diagnostics, and the wider healthcare system.
October 9, 2024
AI / Machine Learning
.png)
Newsletter Update
Clinical Diagnostics
Digital Health and Informatics - Q3 2024 Update
Q3 2024 saw various developments in the digital health and informatics space.
October 8, 2024
.png)
Newsletter Update
Clinical Diagnostics
Digital Health and Informatics - Q3 2024 Update
Q3 2024 saw various developments in the digital health and informatics space.
October 8, 2024
Digital Health
Health Technology Market
Women's Health
Medical Devices

DeciBio Q&A
Clinical Diagnostics
Exploring Proteomics: New Approaches to Early Cancer Detection
Ashkan Afshin, Founder of Novelna, shares insights on using proteomics for early cancer detection and offers his perspectives on the early cancer detection and precision medicine landscapes.
October 2, 2024

DeciBio Q&A
Clinical Diagnostics
Exploring Proteomics: New Approaches to Early Cancer Detection
Ashkan Afshin, Founder of Novelna, shares insights on using proteomics for early cancer detection and offers his perspectives on the early cancer detection and precision medicine landscapes.
October 2, 2024
Immuno-Oncology
Proteomics Market
.png)
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics Newsletter | September Roundup 2024
Read about the latest updates in the Next-Generation Therapeutics space in the month of September.
October 1, 2024
.png)
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics Newsletter | September Roundup 2024
Read about the latest updates in the Next-Generation Therapeutics space in the month of September.
October 1, 2024
Next-Generation Therapeutics

Blog Article
Pharma & Biotech
The UAE's Emerging Role in Global Biotech and Precision Medicine
We explore the UAE’s emerging position as a global precision medicine and biotech hub.
September 24, 2024

Blog Article
Pharma & Biotech
The UAE's Emerging Role in Global Biotech and Precision Medicine
We explore the UAE’s emerging position as a global precision medicine and biotech hub.
September 24, 2024
Health Technology Market
Clinical Diagnostics

Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved